Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)
Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)
Active, not recruiting · NCT06721871 · Registry updated 2026-06-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID) | Congenital Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, microvillus inclusion disease | Active, not recruiting | Phase 2 / Phase 3 | 2026-06-09 | NCT06721871 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Napo Pharmaceuticals, Inc. | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Al Jalila Children's Hospital | Dubai | United Arab Emirates | 3 |
| Boston Children's Hospital | Boston | United States | 343 |
| UOS Gastroenterolgia e Riabilitazione nutrizionale Piazza Sant' Onofrio 4 | Rome | Italy | 1 |